Cellulite Treatment
Velashape is designed for use in medical, aesthetic practices. This treatment provides a toning and firming of the skin surface, temporary improvement to the appearance of cellulite and a temporary reduction to the circumference of treated areas. In addition, by increasing local blood circulation it can provide relief from minor aches and muscle spasms.
The system is safe, effective and FDA approved, combining the following technologies:-
Infra-red (IR) optical energy
Bipolar Radio frequency (RF)
Vacuum Suction with mechanical manipulation
The IR and RF technologies work together to provide dermal and sub-dermal heating. The vacuum and mechanical manipulations improve blood circulation, enhance lymphatic drainage and increase the metabolic rate of the adipose tissue.
Velashape Treatment Summary
Before your Treatment
- Shaving – shave the area to be treated the day before as hair may hinder the smooth movement of the applicator and overheat the treatment area (do not wax).
- Exfoliation -exfoliate the skin 48hrs before the treatment.
- Perfumes/Lotions – do not apply to the treatment area.
- Tanning beds/tanning lotions/creams – do not use 2 weeks prior to or throughout the course of treatments.
- Drugs – Avoid anticoagulants such as Aspirin throughout the treatment, as anticoagulants increase the possibility of bruising.
- Heat – During the treatment you will feel suction and heat to the treatment area. The indication that the treatment is working is the point at which you can tolerate no further heat, known as the “end point.”
After your Velashape Treatment
After the treatment your skin may be slightly pink and you will feel heat in the treatment area for approximately 10-30 minutes.
- Potential Problems/Risks of Velashape Treatment
- Mild discomfort – from the heat sensation
- Excessive skin redness (Erythema)
- Hair pinching – (to body hair)
- Bruising – Uncommon
- Changes to natural skin texture – (scratching, crusting, blister, burn)
- Treating over Tattoos – possible risk of fading










